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Solid-state NMRThe human chemokine receptor CXCR1 is a G-protein coupled receptor that has been successfully expressed
in E. coli as inclusion bodies, and puriﬁed and refolded in multi-milligram quantities required for structural
studies. Expression in E. coli enables selective and uniform isotopic labeling with 13C and 15N for NMR studies.
Long-term chemical and conformational stability and oligomeric homogeneity of CXCR1 in phospholipid bi-
layers are crucial for structural studies under physiological conditions. Here we describe substantial reﬁne-
ments in our previously described puriﬁcation and reconstitution procedures for CXCR1 in phospholipid
bilayers. These reﬁnements have led to the preparation of highly puriﬁed, completely monomeric, proteoli-
posome samples that are stable for months at 35 °C while subject to the high power radiofrequency irradia-
tions of solid-state NMR experiments. The principal changes from the previously described methods include:
1) ensure that CXCR1 is pure and homogeneously monomeric within the limits of detection (>98%); 2) mon-
itor and control the pH at all times especially following the addition of TCEP, which serves as a reducing agent
but also changes the pH; 3) slowly refold CXCR1 with the complete removal of all traces of SDS using a KCl
precipitation/dialysis method; and 4) ensure that the molar ratio between the CXCR1 and the phospholipids
does not change during refolding and detergent removal. NMR samples prepared with these protocols yield
reproducible results over a period of many months at 35 °C. This puriﬁcation and refolding protocol is likely
to be applicable with minimal changes to other GPCRs as well as other membrane proteins.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
G-protein coupled receptors (GPCRs) are important targets for
structural studies. Not only because they represent the largest and
most diverse protein family in the human genome [1–3], but also be-
cause of their roles as receptors for many therapeutic drugs. Currently,
more than one-third of all approved drugs utilize a small fraction of
the total number of GPCRs as receptors; currently unused and orphan
receptors offer many potential targets for the discovery of new drugs
[4–6].
It is essential to determine the three-dimensional structures of
GPCRs in their native bilayer environment in order to understand
their molecular mechanisms of action, and to lay the groundwork
for structure-based drug discovery. However, with only six unique-phosphocholine; DMPC, 1,2-
osphocholine; GST, glutathione
eethane-sulfonic acid; HPC,
xtrin; MAS, magic angle spin-
te; TCEP, tris-2-carboxyethyl-
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l rights reserved.GPCR structures determined at the present time [7–13], structural in-
formation about this class of membrane proteins remains sparse. This
is largely due to the difﬁculties encountered in sample preparation for
the experimental structure determination of large integral membrane
proteins, such as GPCRs with their low expression levels, instability in
the presence of detergents, resistance to crystallization of the native
proteins in any environment, much less phospholipid bilayers for X-
ray diffraction, and their slow overall reorientation in aqueous solu-
tion for solution NMR. In contrast, solid-state NMR is well suited for
structure determination of proteins in supramolecular assemblies,
such as GPCRs in phospholipid bilayers under physiological condi-
tions of temperature, pH, hydration, etc. However, solid-state NMR
experiments require extremely high quality and stable samples in
order to generate meaningful and reproducible results.
Solubilization-induced instabilities and structural heterogeneities
may be limiting factors in the formation of three-dimensional crystals
of GPCRs for X-ray diffraction. In response, the X-ray crystallography
community has creatively and aggressively tackled this problem
through extensive modiﬁcations of both the lipid environment and
the proteins themselves, using truncation, mutagenesis, and the in-
sertion of an additional protein, generally T4 lysozyme, into the se-
quence. GPCRs and other membrane proteins are often crystallized
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types of detergents and lipids [8,13,14]. However, a major concern
is that the crystallization of a membrane protein from monoolein in
LCP alters the protein structure [15].
In addition to providing a native, functional environment that is
likely to be compatible with the biologically active conformation,
there are additional reasons why studying membrane proteins in
phospholipid bilayers is preferred over other membrane-mimic envi-
ronments. For example, many fewer control experiments are required
to ensure that the protein is in its native conformation, other mole-
cules such as chemokines, cholesterol, and drugs can be readily
added to the samples, and the experiments can be performed over a
wide range of relevant temperatures, e.g. 20 °C to 70 °C. However,
proteoliposome samples are not without their own concerns; for ex-
ample, structural changes, which may not be uniform throughout the
protein or the sample, may result from the lateral pressure of
~30 nMm−1 [16], which acts on membrane proteins embedded in
lipid bilayers but not in micelles or isotropic bicelles. While mem-
brane proteins that function as pores or channels may be relatively
unaffected, this lateral pressure may have a strong impact on mem-
brane proteins, such as GPCRs, that interact with multiple other pro-
teins and partners in the membrane, and undergo conformational
changes as part of their function.
For X-ray crystallography, the lipids and proteins have been highly
developed in order to make samples compatible with the available X-
ray beams and instrumentation. In contrast, in solid-state NMR, it is
the instrumentation and spectroscopic methods that have been high-
ly developed to accommodate the protein and phospholipid bilayers
in their native states under physiological conditions. Solid-state
NMR is used to study many types of membrane associated peptides
and proteins in planar phospholipid bilayers [17]. Besides structure
determination, NMR experiments also provide information about
protein dynamics, protein–protein interactions, and protein–lipid in-
teractions [18–24]. Sample development has also been important to
the success of the NMR experiments [25], since the spectra are sensi-
tive to any changes in conformation or aggregation over the extensive
periods of signal averaging required to perform multi-dimensional
experiments on these relatively large proteins.
Whether GPCRs are expressed into membranes [26–30] or inclu-
sion bodies [31–33] in bacteria, or are expressed in cell-free systems
[34–36], detergents are typically required to solubilize these hydro-
phobic proteins for isolation and puriﬁcation. While membrane pro-
teins are stable in their native environment of the liquid crystalline
phospholipid bilayer, they often exhibit changes in structure and ag-
gregation when solubilized with detergents. There are an increasing
number of reports describing how the structures of membrane pro-
teins in the presence of detergents differ from those in phospholipid
bilayers [37–39]. Thus, the use of detergents or other non-native
lipids to solubilize or crystallize a membrane protein requires exten-
sive control experiments to demonstrate that the membrane-mimic
environment does not perturb the structure and dynamics.
Here we describe improved methods of preparation of GPCR-
containing phospholipid bilayers that supersede our previously de-
scribed methods [40,41]. They provide monodisperse, stable, func-
tional samples suitable for NMR studies. We utilize a member of the
rhodopsin-class of GPCRs, the chemokine receptor CXCR1, as an ex-
ample, but the methods should be generally applicable to many
other GPCRs, especially those in this class. Our previous approach to
bacterial expression and puriﬁcation has yielded pure isotopically la-
beled CXCR1 in multi-milligram quantities [41]. However, although
these samples displayed excellent quality in all biochemistry labora-
tory tests, and yielded high-resolution NMR spectra, they tended to
become unstable after one or few days in an NMR spectrometer.
This did not provide sufﬁcient time for performing the long-term sig-
nal averaging necessary for the three-dimensional experiments that
are essential for the assignment of resonances on such a large protein.2. Materials and methods
2.1. Materials
DMPC, DPC, and HPC were obtained from Affymetrix, Inc. (www.
affymetrix.com). DHPC was obtained from Avanti polar lipids, Inc.
(www.avantilipids.com). SDS, TCEP, and MβCD were obtained from
Sigma-Aldrich (www.sigmaaldrich.com).
2.2. Expression and puriﬁcation
The cloning, expression, and puriﬁcation of isotopically labeled
CXCR1 were performed as described previously [40, 41]. The DNA se-
quence coding for human full-length CXCR1 was cloned into the
pGEX2a vector containing the fusion partner GST. The fusion protein
GST-CXCR1-6His was over-expressed in E. coli BL21 using standard
M9 minimal media with 15N labeled ammonium sulfate (Cambridge
Isotope Laboratories, Inc.; www.isotope.com) as the nitrogen source.
The expressed GST-CXCR1-6His polypeptide was predominantly in
inclusion bodies (IBs). It was solubilized in the binding buffer con-
taining 1% (w/v) SDS and puriﬁed to homogeneity by nickel afﬁnity
(Ni-NTA agarose, Qiagen Inc., www.qiagen.com) and size exclusion
(HiLoad™ 26/60 Superdex™ 200 pg, GE Healthcare Bio-Sciences AB;
www.gelifesciences.com) chromatographies. 0.1% (w/v) TCEP as a re-
ducing agent was added to the buffer in the puriﬁcation process by
nickel afﬁnity chromatography. The fusion protein was cleaved with
thrombin in the buffer containing 0.1% (w/v) HPC, and the GST por-
tion was removed from CXCR1-6His immobilized on the nickel afﬁn-
ity column. CXCR1-6His was then eluted from the column with the
buffer containing 0.1% (w/v) DPC and 300 mM imidazole. The protein
concentration was determined spectrophotometrically by measuring
the absorbance at 280 nm, and comparing it to the theoretical molar
extinction coefﬁcient of 51,980 M−1 cm−1.
2.3. Reconstitution
CXCR1 was reconstituted using DMPC. Mixed micelle solutions
were prepared by dissolving the DMPC powder with 0.5% SDS in
20 mM HEPES buffer pH 7.3, 50 mM NaCl with a ﬁnal lipid concentra-
tion of 10 mg/ml. Puriﬁed monomeric CXCR1 was added to the mixed
micelle solution at a protein-to-lipid ratio of 1:10 or 1:5 (w/w) and
incubated for 1 h at room temperature.
(1.) Adsorption to BioBeads. After incubation, the SDS was removed
from the mixture by adsorption to BioBeads (Calbiosorb adsor-
bent, EMD Chemicals; www.emdchemicals.com). The BioBeads
were washed and equilibrated with 20 mM HEPES buffer, pH
7.3, containing no detergent. The required amount of adsor-
bent for detergent removal was calculated (adsorption capaci-
ty for SDS: 94 mg/ml bead slurry) and added directly to the
ternary mixture of lipid, detergent and protein. After 2 h of in-
cubation at room temperature under gentle agitation, the mix-
ture was passed over a column with 90 μm ﬁlter pore size (Mo
Bi Tec, Germany; www.mobitec.com), the detergent-free ﬂow-
through was collected, and the proteoliposomes were recov-
ered by ultracentrifugation (145,000 g, 2 h, 15 °C, Beckman Ti
70.1 rotor).
(2.) Complexation to methyl-β-cyclodextrin. After incubation, the
SDS was removed from the mixture by complexation with
MβCD. Based on the SDS alkyl-chain length a 1:2 complex be-
tween SDS and MβCD was assumed. To remove SDS gently, di-
alysis tubing (Spectra/Por; MWCO 15,000, Cole-Parmer; www.
coleparmer.com) containing the ternary mixture was dialyzed
against >200-fold excess volume containing the correspond-
ing amount of MβCD in 20 mM HEPES buffer, pH 7.3 overnight
at room temperature. The reconstituted suspension of
Expression of GST-CXCR1 as inclusion bodies in E. coli 
Ni affinity chromatography of GST-CXCR1
Enzymatic cleavage of GST using thrombin
Size exclusion chromatography of CXCR1
Reconstituiton of monomeric CXCR1 in lipid bilayers
NMR experiments
solubilization of IBs in SDS
buffer exchange to HPC
elution of CXCR1
removal of SDS
lipid analysis and activity test
Fig. 1. Schematic ﬂow chart of the expression, puriﬁcation and refolding procedures of
CXCR1 as detailed in the Materials and methods.
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Beckman Ti 70.1 rotor), resuspended, and washed with
20 mM HEPES buffer, pH 7.3 to remove any excess MβCD.
(3.) Co-precipitation with potassium chloride. After incubation, the
SDS was precipitated from the solution by the addition of po-
tassium chloride. To remove SDS gently, dialysis tubing con-
taining the ternary mixture was dialyzed against >200-fold
excess volume containing 20 mM HEPES buffer, pH 7.3 over-
night at room temperature, followed by >200-fold excess vol-
ume of 20 mM HEPES buffer, pH 7.3 containing 20 mM KCl for
6 h. The proteoliposomes were ultracentrifuged (145,000 g,
2 h, 15 °C, Beckman Ti 70.1 rotor), resuspended, and washed
with HEPES buffer pH 7.3 to remove any residual KCl.
2.4. Lipid analysis
To monitor quantitatively the lipid and detergent content of the
proteoliposomes, HPLC analysis using an Evaporative Light Scattering
Detection (ELSD) system (Sedex 75; www.sedere.com) was per-
formed. A LiChrosphere 100 NH2 column (EMD Chemicals) was
used as a stationary phase, and the mobile phase was acetonitrile/
methanol/0.1 M ammonium acetate pH 4.8, 70:20:10 (v/v). The sam-
ples were diluted in the running buffer before being loaded onto the
column. After separation on the column, the analytes were evaporat-
ed under a stream of N2, and the non-volatile components were
detected by light scattering. The photomultiplier signal is nearly line-
ar to the analyte concentration.
2.5. Bicelle preparation
For solution NMR, isotropic bicelle samples were prepared by add-
ing 400 mMDHPC to the puriﬁed protein reconstituted into DMPC lipo-
somes to produce q=0.1 isotropic bicelles. Therefore, proteoliposomes
consisting of 1 mg protein reconstituted in 10 mg of DMPC in 20 mM
HEPES buffer, pH 7.3 were collected by centrifugation at 300,000 g for
2 h at 15 °C. Themolar ratio of lipids to proteinwas 605:1. The resulting
supernatant was discarded, and the hydrated proteoliposome pellet
was resuspended in 400 μl waterwith 10% 2H2O containing an adequate
amount of DHPC in order to produce q=0.1 isotropic bicelles.
The magnetically alignable bilayer samples for OS solid-state NMR
spectroscopy were prepared similarly, using higher protein concen-
trations (4 mg protein and 40 mg of DMPC) and an increased q
value of 3.2 for DMPC:DHPC bicelles and 5.0 for DMPC:Triton X-100
bicelles with DMPC concentration of 20% (w/v) in a 200 μl volume.
The resulting mixture was vortexed thoroughly, and then allowed
to equilibrate at room temperature. Upon bicelle formation, proteoli-
posome becomes a clear, non-viscous solution at 4 °C and forms a gel-
like liquid crystalline solution at 30 °C–45 °C. A small, ﬂat-bottomed
NMR tube with 5 mm outer diameter (New Era Enterprises, Inc.;
www.newera-spectro.com) was ﬁlled with 160 μl of the solution
using a precooled pipette at 4 °C. The NMR tube was sealed with a
tight-ﬁtting rubber cap, pierced with a thin syringe to remove air
from the sample and create a tight seal, and used for the stationary
solid-state NMR experiments.
2.6. NMR experiments
The solution NMR experiments were performed at 50 °C on a Varian
VNMRS 800 MHz spectrometer equipped with 5 mm triple-resonance
cold probe and z-axis gradient. 1H/15N HSQC NMR experiments were
performed on uniformly 15N labeled samples in q=0.1 isotropic
bicelles with a protein concentration of ~60 μM.
The 15N and 31P solid-state NMR spectra were obtained on a Bruker
Avance spectrometer with a 1H resonance frequency of 700 MHz. The
homebuilt 1H/15N double-resonance probe had 5 mm inner diameter
solenoid coil tuned to the 15N frequency, and an outer MAGC coiltuned to the 1H frequency [42]. The 31P solid-state NMR spectra were
obtained using a homebuilt 1H/31P double-resonance probe equipped
with double-tuned scroll coil [43]. The one-dimensional 31P NMR spec-
tra were obtained by direct excitation with a single pulse using a 6 s re-
cycle delay; 64 scans were signal averaged with a 10 ms acquisition
time for each spectrum. Continuous wave 1H decoupling utilized a B1
radio frequency ﬁeld strength of 42 kHz during the acquisition period.
The one-dimensional 15N solid-state NMR spectra were obtained by
spin-lock cross-polarization [44] with a contact time of 1 ms, a recycle
delay of 6 s, and an acquisition time of 10 ms. 2048 transients were
co-added, and an exponential function corresponding to 50 Hz of line
broadening was applied prior to Fourier transformation. The three-
dimensional HETCOR/SLF spectrum was obtained with a B1 ﬁeld for
1H during t1 of 50 kHz, otherwise 45 kHz. The data were zero ﬁlled
and yielded a 1024×64×64 real matrix. The 0.33 scaling factor was ap-
plied in the 1H shift dimension.
3. Results and discussion
As described in earlier publications [40,41], we have established
an E. coli expression system capable of providing the multi-
milligram quantities of CXCR1 required for NMR structural studies,
which enabled us to obtain initial NMR spectra. The reﬁnements of
the preparation procedures described here provide samples that are
stable for many months at room temperature, enabling reproducible
multidimensional NMR spectra to be obtained. These spectra are
used to determine the structures and describe the dynamics of
GPCRs. There are several different reﬁnements in the puriﬁcation
and reconstitution procedures. The procedures are now highly repro-
ducible, and essentially all samples prepared in the laboratory are
pure, monomeric, and stable for many months.
3.1. CXCR1 monodispersity
The protocol for the preparation of stable samples of CXCR1 in
lipid bilayers outlined in Fig. 1 is very efﬁcient. It takes 3 days from
the bacterial culture to the ﬁnal NMR sample: day 1, growth of E.
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day 3, preparation of CXCR1 proteoliposomes and the ﬁnal NMR sam-
ple. The sample purity at each step is monitored by SDS-PAGE (Fig. 2):
lane 1, the expression of the fusion protein and its partial puriﬁcation
by isolation of the inclusion bodies; lane 2, the removal of the GST fu-
sion partner following cleavage on the nickel afﬁnity column; and
lane 3, the presence of CXCR1 and a few other polypeptides. The
ﬁnal puriﬁcation by size exclusion chromatography yields pure, mo-
nomeric CXCR1, as shown in lanes 4 and 5 of Fig. 2. The protein purity
was shown to be >98% by gel quantiﬁcation analysis (ImageJhttp://
rsb.info.nih.gov/ij/).
The CXCR1 samples puriﬁed by nickel afﬁnity chromatography that
contain a small amount of higher oligomers (Fig. 2, lane 3) must be im-
mediately loaded onto the size exclusion chromatography.We ﬁnd that
trace amount of oligomers (and/or other impurities) apparently facili-
tate the formation of larger amounts of higher oligomers. As a result
any delay between the two chromatography steps signiﬁcantly reduces
the yield of the monomeric protein.
Previously, we added TCEP as a reducing agent during the entire
process of the CXCR1 sample preparation in order to improve the sam-
ple stability by preventing oligomerization through the formation of
non-speciﬁc intermolecular disulﬁde bonds. However, we ﬁnd that
the presence of TCEP in the monomeric form of CXCR1 does not affect
the sample monodispersity and therefore TCEP is added only to the
buffer in the nickel afﬁnity chromatography. The pH is adjusted imme-
diately following the addition of TCEP.
3.2. Improvement of the stability of CXCR1 proteoliposomes
The most successful strategy for the reconstitution of integral
membrane proteins into proteoliposomes is a reﬁnement of our pre-
viously described methods [40,41]. The optimized approach relies on
the precisely controlled pH and complete removal of the detergent
from ternary solutions of protein, lipids and detergents in excess
water. The removal of the detergent, which is included initially to sol-
ubilize the hydrophobic membrane protein, is essential for forming
stable bilayers, and must be performed in a precise and quantitative
manner to avoid the formation of protein oligomers. We emphasize
that we have found that even the smallest trace of protein oligomers
is problematic for the preparation of stable samples. This is not the
case for many other proteins, but it certainly is for CXCR1 and116.3
97.4
66.3
55.4
36.5
31.0
21.5
14.4
6.0
54321M
Fig. 2. SDS-PAGE analysis of the puriﬁcation and refolding procedure: lane 1, inclusion
bodies of the GST-CXCR1 fusion protein; lane 2, GST in ﬂow through after thrombin
cleavage of fusion protein; lane 3, puriﬁed CXCR1 by Ni afﬁnity chromatography;
lane 4, puriﬁed monomer faction of CXCR1 by size exclusion chromatography; lane 5,
monomeric CXCR1 proteoliposome reconstituted in DMPC bilayers. The band at
about 31 kDa corresponds to the CXCR1 monomer.presumably other GPCRs and perhaps other relatively large mem-
brane proteins.
Proteoliposomes were formed from a co-solubilized ternary com-
plex of lipid, protein and detergent. The reconstitution of CXCR1 into
phospholipid bilayers by removing the detergent is a key step in the
refolding process. CXCR1 puriﬁed from bacterial inclusion bodies and
reconstituted into proteoliposomes has previously been shown to be
functional [41]. The purity and homogeneity of the reconstituted pro-
tein is of crucial importance for OS solid-state NMR experiments, since
the sample alignment in lipid bilayers is strongly dependent on a pre-
cise lipid ratio [45]. The strong interaction of CXCR1 prepared from
the proteoliposomeswith its physiological ligand interleukin-8 was ob-
served byNMR spectroscopy,which further demonstrates the function-
ality of CXCR1 proteoliposomes [46].
The ﬁnal yield of reconstituted protein in liposomes is strongly re-
lated to the procedure used to remove the detergent from the ternary
protein:lipid:detergent solution, as well as the nature of the phospho-
lipids used during the co-solubilization process. We were able to ob-
tain the best results by using SDS, and improving the method for
removal of SDS during the reconstitution of CXCR1 into DMPC phos-
pholipid bilayers. Three different techniques for the removal of SDS
were compared: (1) adsorption to BioBeads; (2) complexation with
methyl-β-cyclodextrin; and (3) co-precipitation with potassium
chloride. We paid particular attention to the quantitative reproduc-
ibility and homogeneity of the CXCR1-containing proteoliposomes.
SDS removal by BioBeads is simple and rapid, and provides an alter-
native to conventional dialysis, especially when dealing with low-CMC
detergents. However, batches of CXCR1-containing proteoliposomes
produced with this approach varied signiﬁcantly in their lipid content
with a total phospholipid loss of up to 20%. Similarﬂuctuationswere ob-
served using non-recycled adsorbent, which excluded altered afﬁnities
due to recycling. The lipid composition was quantitatively and qualita-
tively monitored by HPLC-ELSD. This approach conﬁrmed the batch
wise inconsistency in the protein-containing DMPC liposomes. The rea-
son for the loss of DMPC may be due to non-speciﬁc adsorption to Bio-
Beads, which is a known limitation of this method [47]. Although the
adsorptive capacity of BioBeads has become more consistent, the total
detergent concentration remains difﬁcult to determine. As a result, the
total amount of detergent bound to CXCR1 can only be estimated, and
this is simply not adequate for the preparation of stable samples for
NMR spectroscopy.
The results of gentle reconstitution using either MβCD or KCl to as-
sist the removal of the detergent during dialysis were similar. MβCD
or KCl was slowly dialyzed against ternary solutions of protein, lipid,
and detergent.WhileMβCD is applicable to a broad range of detergents
containing long acyl chains [48], KCl is only suitable for detergents hav-
ing sulfate head groups, speciﬁcally SDS [49]. In contrast to procedures
that used BioBeads, SDS removal by either MβCD or KCl was highly re-
producible and yielded proteoliposomes without loss of long chain
lipids. Care must be taken, since the rapid reconstitution that results
from direct addition of MβCD or KCl to the ternary solution causes pro-
tein oligomerization that is readily observable by SDS-PAGE. The timing
of the reconstitution was optimized to minimize protein oligomeriza-
tion. The ternary solution was ﬁrst dialyzed overnight against >200-
fold excess volume of a buffer (20 mM HEPES, pH 7.3) to remove the
bulk of the SDS, and thendialyzed against a buffer containing the appro-
priate amount of MβCD with respect to the sample volume overnight,
or 20 mMKCl for 6 h to remove any SDS bound to the proteoliposomes.
Although both methods give similar results, we primarily use the KCl
co-precipitation method because it is speciﬁc to SDS, easier to setup,
and less expensive than the MβCD complexation method. In Fig. 3,
lipid analysis by HPLC-ELSD clearly shows that all of the SDS is removed
(within detection limits) by the KCl co-precipitation method.
GPCRs in phospholipids following the removal of detergents are in-
termediates in the preparation of protein-containing samples for either
solution NMR or solid-state NMR spectroscopy. In one approach, the
retention time (ml)
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Fig. 3. HPLC-ELSD chromatogram of lipid mixtures in CXCR1 samples. (A) Ternary complex of CXCR1, DMPC and SDS mixtures before reconstitution. (B) CXCR1 proteoliposome
after removal of SDS by co-precipitation with KCl.
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bilayer-disks that consist of long chain lipids that form a bilayer in the
center, and are ﬂanked by short chain lipids at the edges. The molar
ratio of long chain and short chain lipid, the q value, is an important pa-
rameter for the alignment properties of bicelles by highmagnetic ﬁelds.
When q is greater than about 2.5, amagnetically aligned bilayer phase is
formed. When q is between 0 and about 1.5, isotropic bicelles are
formed that undergo relatively rapid and isotropic reorientation in
aqueous solution. Although, some membrane proteins have been dem-
onstrated to be functional in bicelle samples [17,24,41,50,51], concern
remains about the presence of detergents (DHPC, CHAPSO, or Triton
X-100) and the slightly reduced overall order parameters of the bilayer
lipids and the protein backbone, which are generally measured to be
about 0.85±0.05. In contrast, in proteoliposomes, both the lipids and
the protein backbone have an order parameter of 1.0.
We have found that the precise molar ratio of lipid to protein is
crucial for stability and function of the protein in proteoliposomes.
This ratio must be optimized, and then maintained in order to have
stable samples for NMR and other physical experiments. For NMR−2040 20 0 -40
31P shift (
C DMPC
DHPC
−2040 20 0 -40
A
DMPC
DHPC
Fig. 4. 31P solid-state NMR spectra of CXCR1 samples aligned magnetically in phospholipid b
q=3.2. (D) DMPC:Triton X-100, q=5.0. The samples are prepared from four different batch
and by co-precipitation of SDS with KCl (C and D). Appropriate amount of DHPC or Triton X
taking into account of the lipid loss after reconstitution. The DMPC and DHPC signals fromspectroscopy, which is always limited by sensitivity, it is essential to
ﬁnd the lowest lipid-to-protein ratio in order to achieve the highest
NMR sensitivity while the ratio remains in a range for the sample to
be stable enough to perform multi-dimensional experiments that
may require days of signal averaging.
Any inconsistency in the amount of the long chain lipid after re-
constitution affects not only the sample stability, but also the produc-
tion of bicelles that consist of both long chain and short chain
phospholipids (or detergents). Any lipid loss impedes an accurate ad-
justment of q by the addition of a short chain lipid DHPC [52] or the
nonionic detergent Triton X-100 [53], resulting in poor alignment
and instability of bicelle samples. The 31P NMR spectra of bicelle sam-
ples prepared from two different batches of CXCR1 proteoliposomes
in which reconstitution was performed using BioBeads demonstrates
how the variation in lipid to detergent ratio affects the magnetic
alignment of the bilayers (Figs. 4A and B). By contrast, bicelle samples
prepared using the KCl co-precipitation method result in excellent
and reproducible alignment in both DMPC:DHPC and DMPC:Triton
X-100 bicelles (Figs. 4C and D). The two resolved signals in Fig. 4ppm)
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es of CXCR1 proteoliposomes reconstituted by adsorption of SDS to BioBeads (A and B)
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Fig. 5. NMR spectra of uniformly 15N-labeled CXCR1 in lipid environments. (A) Two-dimensional 1H-15N HSQC solution NMR spectrum of CXCR1 in DMPC:DHPC (q=0.1) isotropic
bicelles. (B) Two-dimensional 1H-15N dipolar coupling/15N chemical shift plane extracted from the three-dimensional spectrum of CXCR1 aligned magnetically in DMPC:Triton X-
100 (q=5.0) bicelles at 1H chemical shift frequency of 14.3 ppm.
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ton X-100 does not contain phosphorus, the 31P NMR spectrum con-
sists of a single signal from aligned DMPC in Fig. 4D.
3.3. NMR studies on wild-type CXCR1 in lipid environments
Representative NMR spectra of uniformly 15N labeled CXCR1 sam-
ples prepared using gentle KCl co-precipitation are shown in Fig. 5.
The 1H/15N HSQC solution NMR spectrum of CXCR1 in q=0.1
DMPC:DHPC isotropic bicelles (Fig. 5A) has homogeneous and repro-
ducible signals, which are from the mobile N- and C-terminal residues
of CXCR1 [20]. The signals from the bulk of the residues in the trans
membrane helices and the inter-helical loops are not observable in
solution NMR spectra because of the slow global reorientation of
CXCR1 in isotropic bicelles.
The same sample preparation methods provide excellent samples
for solid-state NMR experiments on the protein reconstituted into
phospholipid bilayers. A typical two-dimensional separated local−2040 20 0 -40
A
C
31P shift (ppm)
DMPC
DHPC
DMPC
DHPC
−2040 20 0 -40
Fig. 6. 31P and 15N solid-state NMR spectra of uniformly 15N-labeled CXCR1 samples aligned
recorded on a freshly prepared sample. (C and D) The spectra were recorded on the same sﬁeld plane extracted from a three-dimensional HETCOR/SLF spectrum
of an aligned q=5.0 DMPC:Triton X-100 bicelle sample of uniformly
15N labeled CXCR1 displays single site resolution, which is essential
for the resonance assignment and structure determination (Fig. 5B).
It is remarkable that there are no signiﬁcant changes in either the
31P NMR or 15N NMR spectra of CXCR1 before and after the multiple
NMR experiments performed over an 8-day period at 35 °C (Fig. 6).
This same sample has been reused over a six month period, and has
always yielded reproducible 31P NMR of the phospholipids and 15N
NMR spectra of the protein.
4. Conclusion
There is a consensus that the most reliable structural data are
obtained from membrane proteins in their native phospholipid bilay-
er environments under physiological conditions, and that the use of
detergents or other non-native lipids in membrane mimics inevitably
leads to controversies about possible perturbations of the protein's200 100 0
B
D
15N shift (ppm)
200 100 0
magnetically in phospholipid DMPC:DHPC bicelles at 35 °C. (A and B) The spectra were
ample after 8 days in the magnet.
590 S.H. Park et al. / Biochimica et Biophysica Acta 1818 (2012) 584–591structure, dynamics, or functions. Following heterologous expression
of a GPCR or other membrane protein as inclusion bodies, refolding of
the proteins by reconstituting them into membrane environments is
the most crucial step in obtaining functional and stable samples.
The stability of the proteoliposomes is strongly related to the purity
and monodispersity of the membrane protein. The concentrated pro-
teoliposomes of integral membrane proteins stabilized in their native
environment of liquid crystalline phospholipid bilayers serve as an
ideal sample for the structural studies by MAS solid-state NMR
methods. Magnetically aligned bilayers produced by addition of DHPC
or TritonX-100 to these sameproteoliposomes provide enhanced align-
ment and stability for structural studies by OS solid-state NMR.
These protocols for sample preparation illustrated with CXCR1
should be generally applicable to a wide range of other helical mem-
brane proteins. We have applied these methods to full-length mem-
brane proteins and truncated domains with between one and seven
trans membrane helices, including constructs of CXCR1, MerF from
the bacterial mercury detoxiﬁcation system, and p7 from the hepatitis
C virus. In all cases, we have seen dramatic improvements in sample
stability under the conditions of NMR experiments.
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